Prostate cancer is the second leading cause of cancer among men, according to the Centers for Disease Control and Prevention ...

Cancer doctors, scientists, and patient advocates said the “cancer” label can do more harm than good, given this form of the ...

New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men.

Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide tablets, a generic prostate cancer treatment drug, for ...

Know about Prostate cancer as it has significant impact on men's health. Here are the details about this disease.

For patients with prostate cancer, theranostics may be another available treatment path to take, especially for those who ...

A new paper in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that patients ...

Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to produce a generic prostate ...

People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation ...

A vital prostate cancer testing drive was held over the weekend, educating people during Cancer Awareness Month, about risk ...

Based on real-world data, Johnson & Johnson (NYSE:JNJ) announced Wednesday its prostate cancer therapy Erleada (apalutamide) ...

Ahmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration ...